Aspira Women's Health Inc. (NASDAQ:AWH) Q4 2020 Earnings Conference Call March 25, 2021 4:30 PM ET Company Participants Valerie Palmieri - President and CEO Robert Beechey - CFO Kaile Zagger - COO Lesley Northrop - Chief Scientific Officer Elena Ratner - Global Chief Medical Advisor and Clinical and Translational Medicine Conference Call Participants Andrew Brackmann - William Blair Kyle Mikson - Cantor Fitzgerald Operator Good afternoon, ladies and gentlemen, and welcome to Aspira Women's Health Fourth Qua ...

Aspira Women's Health Inc. (NASDAQ:AWH) Q3 2020 Earnings Conference Call November 12, 2020 4:30 PM ET Company Participants Valerie Palmieri - CEO, President & Director Robert Beechey - CFO Conference Call Participants Operator Hello ladies and gentlemen. Good afternoon, and welcome to Aspira Women's Health Third Quarter 2020 Conference Call. My name is Jane, and I will be your coordinator for the call today. [Operator Instructions] As a reminder, this conference is being recorded today. Leading the call tod ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-34810 Aspira Women's Health Inc. (Exact name of registrant as specified in its charter) Delaware 33-0595156 ( ...

Aspira Women's Health, Inc. (NASDAQ:AWH) Q2 2020 Earnings Conference Call August 13, 2020 4:30 PM ET Company Participants Valerie Palmieri - CEO, President & Director Lesley Northrop - Global Medical Director, Genetic Services Robert Beechey - CFO Conference Call Participants Andrew Brackmann - William Blair & Company Operator Good afternoon, and welcome to Aspira Women's Health Second Quarter 2020 Conference Call. My name is Jessie, and I will be your coordinator for the call today. [Operator Instructions] ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-34810 Aspira Women's Health Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | |----- ...

Vermillion, Inc. (VRML) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants Valerie Palmieri – President and Chief Executive Officer Chris Goulart – Senior Vice President of Commercial Operations Bob Beechey – Chief Financial Officer Conference Call Participants Brian Weinstein – William Blair Jeb Terry – Aberdeen Investment Management Kyle Mikson – Cantor Fitzgerald Operator Good afternoon, ladies and gentlemen, and welcome to Vermillion's First Quarter 2020 Conference Call. My na ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-34810 Vermillion, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0595156 (State or other ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-34810 Vermillion, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0595156 (State or Other Jurisd ...

VRML (VRML) Q4 2019 Results Conference Call March 26, 2020 4:30 PM ET Company Participants Valerie Palmieri - President and CEO Bob Beechey - CFO Chris Goulart - SVP, Commercial Operations Conference Call Participants Jeb Terry - Aberdeen Investment Management Jack Fraser - Seamark Capital Operator Good afternoon, ladies and gentlemen, and welcome to the Vermillion’s Fourth Quarter 2020 (sic) [2019] Conference Call. My name is Doug, and I will be your coordinator for the call today. At this time, all partic ...